| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 17.040 | 16.635 | 11.455 | 9.785 | 9.734 | 17.743 | 7.784 | 9.353 | 16.012 |
| Total Income - EUR | - | 17.040 | 19.244 | 17.252 | 9.787 | 9.734 | 17.743 | 7.786 | 9.354 | 16.012 |
| Total Expenses - EUR | - | 82 | 2.760 | 5.995 | 98 | 108 | 155 | 894 | 342 | 8.139 |
| Gross Profit/Loss - EUR | - | 16.958 | 16.484 | 11.258 | 9.689 | 9.626 | 17.588 | 6.891 | 9.012 | 7.874 |
| Net Profit/Loss - EUR | - | 16.447 | 15.985 | 10.914 | 9.396 | 9.358 | 17.066 | 6.662 | 7.743 | 6.639 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ct Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 56 | 16 | 15 | 15 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 16.947 | 19.990 | 12.123 | 16.845 | 23.406 | 30.223 | 8.372 | 16.289 | 9.251 |
| Inventories | - | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 13.311 | 15.199 | 4.986 | 6.808 | 23.209 | 25.756 | 4.594 | 15.198 | 5.439 |
| Cash | - | 3.622 | 4.791 | 7.137 | 10.036 | 197 | 4.467 | 3.778 | 1.091 | 3.812 |
| Shareholders Funds | - | 16.492 | 16.493 | 10.966 | 16.378 | 23.249 | 30.010 | 6.711 | 14.434 | 6.788 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 511 | 3.512 | 1.173 | 482 | 156 | 213 | 1.661 | 1.856 | 2.463 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ct Clinical Research Srl